Skip to main content
Erschienen in: Digestive Diseases and Sciences 8/2021

26.08.2020 | Original Article

Association of Eosinophilic Esophagitis and Human Immunodeficiency Virus

verfasst von: Mohammad Maysara Asfari, Katherine Kendrick, Muhammad Talal Sarmini, Pearl Uy, Kenneth J. Vega

Erschienen in: Digestive Diseases and Sciences | Ausgabe 8/2021

Einloggen, um Zugang zu erhalten

Abstract

Background

Eosinophilic esophagitis (EoE) is thought to be an atopic disorder causing dysphagia. HIV patients have dysphagia from both common (reflux esophagitis) and uncommon causes (idiopathic esophageal ulceration). Only a single case report about the occurrence of EoE in an HIV patient exists in literature.

Aim

The aim of this study was to determine if HIV and EoE occur concurrently using a large inpatient database.

Methods

Data on hospital admissions of all HIV adult patients were extracted from the 2002–2014 National Inpatient Sample. Comorbidities and outcomes of interest were defined by querying all diagnostic and procedural fields for the corresponding ICD-9 codes. Univariable and multivariable logistic regression analysis was performed to assess the association between HIV and EoE. Similarly, we assessed the relation between HIV and eosinophilic gastroenteritis (EGE).

Results

The total population comprised of 101,137,145 patients, of which 231,691 (0.229%) have HIV and 5038 (0.004%) have EoE. HIV patients were younger (45.2 vs 48 years old and more likely to be male (62.2% vs 41.5%) and African American (53.9% vs 14.2%) compared to non-HIV patients (P < 0.001 for all). After adjusting for potential cofounding factors, HIV patients had a statistically significant higher rate of EoE (Odds Ratio 2.108, with 95% confidence interval 1.268-3.506, P = 0.004) compared to the non-HIV group. On the other hand, HIV was not associated with increased risk of EGE (Odds Ratio 0.78, 95% confidence interval 0.109-5.557, P = 0.804).

Conclusion

Patients with HIV are twice as likely to have EoE compared to those without HIV. Evaluation of dysphagia in HIV patients should include assessment for EoE, especially when empiric antifungal therapy for candida esophagitis does not improve clinical symptoms.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Kahwash B, Prasad V. Eosinophilic esophagitis: a brief review. Ibnosina J Med Biomed Sci. 2017;7:158.CrossRef Kahwash B, Prasad V. Eosinophilic esophagitis: a brief review. Ibnosina J Med Biomed Sci. 2017;7:158.CrossRef
2.
Zurück zum Zitat Hirano I, Collins MH, Assouline-Dayan Y, et al. RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology. 2019;156:592.e10–603.e10.CrossRef Hirano I, Collins MH, Assouline-Dayan Y, et al. RPC4046, a monoclonal antibody against IL13, reduces histologic and endoscopic activity in patients with eosinophilic esophagitis. Gastroenterology. 2019;156:592.e10–603.e10.CrossRef
3.
Zurück zum Zitat Merves J, Muir A, Chandramouleeswaran PM, et al. Eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2014;112:397–403.CrossRef Merves J, Muir A, Chandramouleeswaran PM, et al. Eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2014;112:397–403.CrossRef
4.
Zurück zum Zitat Cianferoni A, Spergel J. Eosinophilic esophagitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50:159–174.CrossRef Cianferoni A, Spergel J. Eosinophilic esophagitis: a comprehensive review. Clin Rev Allergy Immunol. 2016;50:159–174.CrossRef
5.
Zurück zum Zitat Sgouros S, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2015;18:211–217.CrossRef Sgouros S, Bergele C, Mantides A. Eosinophilic esophagitis in adults: a systematic review. Eur J Gastroenterol Hepatol. 2015;18:211–217.CrossRef
6.
Zurück zum Zitat Prasad G, Alexander J, Schleck C, et al. Epidemiology of eosinophilic esophagitis over 3 decades in Olmsted county, Minnesota. Clin Gastroenterol Hepatol. 2011;7:1055–1061.CrossRef Prasad G, Alexander J, Schleck C, et al. Epidemiology of eosinophilic esophagitis over 3 decades in Olmsted county, Minnesota. Clin Gastroenterol Hepatol. 2011;7:1055–1061.CrossRef
7.
Zurück zum Zitat Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115:418–419.CrossRef Straumann A, Simon HU. Eosinophilic esophagitis: escalating epidemiology? J Allergy Clin Immunol. 2005;115:418–419.CrossRef
8.
Zurück zum Zitat Batog C, Psevdos G, Paniz-Mondolfi A, et al. Eosinophilic oesophagitis: an unsuspected aetiology for dysphagia in an HIV-positive patient. Int J Std AIDS. 2010;21:842–844.CrossRef Batog C, Psevdos G, Paniz-Mondolfi A, et al. Eosinophilic oesophagitis: an unsuspected aetiology for dysphagia in an HIV-positive patient. Int J Std AIDS. 2010;21:842–844.CrossRef
9.
Zurück zum Zitat Noel R, Putnam P, Rothenberg M. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–941.CrossRef Noel R, Putnam P, Rothenberg M. Eosinophilic esophagitis. N Engl J Med. 2004;351:940–941.CrossRef
10.
Zurück zum Zitat Liacouras C, Furuta G, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.CrossRef Liacouras C, Furuta G, Hirano I, et al. Eosinophilic esophagitis: updated consensus recommendations for children and adults. J Allergy Clin Immunol. 2011;128:3–20.CrossRef
11.
Zurück zum Zitat Dellon E, Jensen E, Martin C, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014;12:589–596.CrossRef Dellon E, Jensen E, Martin C, et al. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol. 2014;12:589–596.CrossRef
12.
Zurück zum Zitat Dellon E, Liacouras C, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis. Proc AGREE Conf. 2019;155:1022–1033. Dellon E, Liacouras C, Molina-Infante J, et al. Updated international consensus diagnostic criteria for eosinophilic esophagitis. Proc AGREE Conf. 2019;155:1022–1033.
13.
Zurück zum Zitat Dellon E. Eosinophilic esophagitis. Gastroenterol Clin N Am. 2013;42:133–153.CrossRef Dellon E. Eosinophilic esophagitis. Gastroenterol Clin N Am. 2013;42:133–153.CrossRef
14.
Zurück zum Zitat Fox V, Nurko S, Furuta G. Eosinophilic esophagitis: it’s not just kid’s stuff. Gastrointest Endosc. 2002;56:260–270.CrossRef Fox V, Nurko S, Furuta G. Eosinophilic esophagitis: it’s not just kid’s stuff. Gastrointest Endosc. 2002;56:260–270.CrossRef
15.
Zurück zum Zitat Straumann A, Katzka D. Diagnosis and treatment of eosinophilic esophagitis. Gastroenterology. 2018;154:346–359.CrossRef Straumann A, Katzka D. Diagnosis and treatment of eosinophilic esophagitis. Gastroenterology. 2018;154:346–359.CrossRef
16.
Zurück zum Zitat Blanchard C, Wang N, Stringer K, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536–547.CrossRef Blanchard C, Wang N, Stringer K, et al. Eotaxin-3 and a uniquely conserved gene-expression profile in eosinophilic esophagitis. J Clin Invest. 2006;116:536–547.CrossRef
17.
Zurück zum Zitat Sherrill J, Gao PS, Stucke E, et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126:160–165.CrossRef Sherrill J, Gao PS, Stucke E, et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol. 2010;126:160–165.CrossRef
18.
Zurück zum Zitat Soumelis V, Reche P, Kanzler H, et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673–680.CrossRef Soumelis V, Reche P, Kanzler H, et al. Human epithelial cells trigger dendritic cell-mediated allergic inflammation by producing TSLP. Nat Immunol. 2002;3:673–680.CrossRef
19.
Zurück zum Zitat Noti M, Wojno E, Kim B, et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Cytokine. 2013;63:310. Noti M, Wojno E, Kim B, et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Cytokine. 2013;63:310.
20.
Zurück zum Zitat Siracusa M, Kim B, Spergel J, et al. Basophils and allergic inflammation. J Allergy Clin Immunol. 2013;132:789–801.CrossRef Siracusa M, Kim B, Spergel J, et al. Basophils and allergic inflammation. J Allergy Clin Immunol. 2013;132:789–801.CrossRef
21.
Zurück zum Zitat Siracusa M, Saenz S, Hill D, et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature. 2011;477:229–233.CrossRef Siracusa M, Saenz S, Hill D, et al. TSLP promotes interleukin-3-independent basophil haematopoiesis and type 2 inflammation. Nature. 2011;477:229–233.CrossRef
22.
Zurück zum Zitat Sherrill J, Annaiah K, Martin L, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–292.CrossRef Sherrill J, Annaiah K, Martin L, et al. Common variants at 5q22 associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–292.CrossRef
23.
Zurück zum Zitat Reed C, Dellon E. Eosinophilic esophagitis. Med Clin N Am. 2019;103:29–42.CrossRef Reed C, Dellon E. Eosinophilic esophagitis. Med Clin N Am. 2019;103:29–42.CrossRef
24.
Zurück zum Zitat Muir A, Lim D, Benitez A, et al. Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro. Exp Cell Res. 2013;319:850–859.CrossRef Muir A, Lim D, Benitez A, et al. Esophageal epithelial and mesenchymal cross-talk leads to features of epithelial to mesenchymal transition in vitro. Exp Cell Res. 2013;319:850–859.CrossRef
25.
Zurück zum Zitat Raheem M, Leach S, Day A, et al. The pathophysiology of eosinophilic esophagitis. Front Pediatr. 2014;2:1–9.CrossRef Raheem M, Leach S, Day A, et al. The pathophysiology of eosinophilic esophagitis. Front Pediatr. 2014;2:1–9.CrossRef
26.
Zurück zum Zitat Lu T, Sherrill J, Wen T, et al. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol. 2012;129:1064–1075.CrossRef Lu T, Sherrill J, Wen T, et al. MicroRNA signature in patients with eosinophilic esophagitis, reversibility with glucocorticoids, and assessment as disease biomarkers. J Allergy Clin Immunol. 2012;129:1064–1075.CrossRef
27.
Zurück zum Zitat Gelpi M, Hartling H, Thorsteinsson K, et al. Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin. BMC Infect Dis. 2016;16:1–9.CrossRef Gelpi M, Hartling H, Thorsteinsson K, et al. Immune recovery in acute and chronic HIV infection and the impact of thymic stromal lymphopoietin. BMC Infect Dis. 2016;16:1–9.CrossRef
28.
Zurück zum Zitat Healthcare Cost and Utilization Project (HCUP). HCUP Elixhauser Comorbidity Software. Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project (HCUP). HCUP Elixhauser Comorbidity Software. Agency for Healthcare Research and Quality
29.
Zurück zum Zitat Sperry S, Woosley J, Shahenn N, et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol. 2012;107:215–221.CrossRef Sperry S, Woosley J, Shahenn N, et al. Influence of race and gender on the presentation of eosinophilic esophagitis. Am J Gastroenterol. 2012;107:215–221.CrossRef
30.
Zurück zum Zitat Rothenberg M, Spergel J, Sherrill J, et al. Common variants at 5q22associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–291.CrossRef Rothenberg M, Spergel J, Sherrill J, et al. Common variants at 5q22associate with pediatric eosinophilic esophagitis. Nat Genet. 2010;42:289–291.CrossRef
32.
Zurück zum Zitat Ridolo E, DeAngelis G, Dallangilo P. Eosinophilic esophagitis after speficif oral tolerance for egg protein. Allergy Asthma Immunol. 2011;106:73–74.CrossRef Ridolo E, DeAngelis G, Dallangilo P. Eosinophilic esophagitis after speficif oral tolerance for egg protein. Allergy Asthma Immunol. 2011;106:73–74.CrossRef
33.
Zurück zum Zitat Kelly K, Lazenby A, Rowe P, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503–1512.CrossRef Kelly K, Lazenby A, Rowe P, et al. Eosinophilic esophagitis attributed to gastroesophageal reflux: improvement with an amino acid-based formula. Gastroenterology. 1995;109:1503–1512.CrossRef
34.
Zurück zum Zitat Becker Y. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are Indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers—a review and hypothes. Virus Genes. 2004;28:5–18.CrossRef Becker Y. The changes in the T helper 1 (Th1) and T helper 2 (Th2) cytokine balance during HIV-1 infection are Indicative of an allergic response to viral proteins that may be reversed by Th2 cytokine inhibitors and immune response modifiers—a review and hypothes. Virus Genes. 2004;28:5–18.CrossRef
Metadaten
Titel
Association of Eosinophilic Esophagitis and Human Immunodeficiency Virus
verfasst von
Mohammad Maysara Asfari
Katherine Kendrick
Muhammad Talal Sarmini
Pearl Uy
Kenneth J. Vega
Publikationsdatum
26.08.2020
Verlag
Springer US
Erschienen in
Digestive Diseases and Sciences / Ausgabe 8/2021
Print ISSN: 0163-2116
Elektronische ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-020-06566-y

Weitere Artikel der Ausgabe 8/2021

Digestive Diseases and Sciences 8/2021 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

ADT zur Radiatio nach Prostatektomie: Wenn, dann wohl länger

24.05.2024 Prostatakarzinom Nachrichten

Welchen Nutzen es trägt, wenn die Strahlentherapie nach radikaler Prostatektomie um eine Androgendeprivation ergänzt wird, hat die RADICALS-HD-Studie untersucht. Nun liegen die Ergebnisse vor. Sie sprechen für länger dauernden Hormonentzug.

„Überwältigende“ Evidenz für Tripeltherapie beim metastasierten Prostata-Ca.

22.05.2024 Prostatakarzinom Nachrichten

Patienten mit metastasiertem hormonsensitivem Prostatakarzinom sollten nicht mehr mit einer alleinigen Androgendeprivationstherapie (ADT) behandelt werden, mahnt ein US-Team nach Sichtung der aktuellen Datenlage. Mit einer Tripeltherapie haben die Betroffenen offenbar die besten Überlebenschancen.

So sicher sind Tattoos: Neue Daten zur Risikobewertung

22.05.2024 Melanom Nachrichten

Das größte medizinische Problem bei Tattoos bleiben allergische Reaktionen. Melanome werden dadurch offensichtlich nicht gefördert, die Farbpigmente könnten aber andere Tumoren begünstigen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.